US FDA to companies: Make Rx drug print ads easier to understand
This article was originally published in SRA
Executive Summary
In a policy shift, the US Food and Drug Administration is calling on pharmaceutical manufacturers to make the risk information they include in their print advertisements and promotions easier for consumers to understand. The agency tells companies how to accomplish this in a newly revised draft guidance1.